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Objectives. This study evaluated the immediate and long-term 
results of percutaneous Inoue balloon mitral valvotomy in pa- 
tients with severe valvular and subvalvular deformity. 
Methods. We reviewed the prevalvotomy transthoracic e hocar- 
diograms of patients from the North American multicenter Inoue 
registry with total Massachusetts General Hospital (MGH) echo- 
cardiographic s ores > 10. The echocardiograms were rescored by 
two investigators to assess valvular and subvalvular morphology 
to eliminate interinstitutional variability. Ninety patients were 
originally assigned scores >10. After rescoring, 18 patients (20%) 
were eliminated, leaving 72 study patients. 
Results. Balloon mitral valvotomy was technically successful in 
69 (96%) of the 72 patients. Mean (-+SD) mitral valve area 
increased from 0.9 -+ 0.3 to 1.5 -+ 0.5 cm 2. An immediate optimal 
result, defined as >50% increase in mitral valve area or a final 
area >1.5 cm 2 with no major complications, was achieved in 46 
patients (64%). End points for clinical follow-up (events) included 
mitral valve replacement, repeat valvotomy or death. At a mean 
follow-up of 22.9 -+ 11.0 months, 22 patients (31%) required 
mitral valve replacement or a second valvotomy, 9 patients (13%) 
died, and 32 patients (45%) were in New York Heart Association 
functional class I or II. Univariate predictors of an immediate 
optimal result included sinus rhythm, male gender and a lower 
University of Southern California commissural calcium score. 
Only sinus rhythm predicted an optimal result by multivariate 
analysis. Actuarial 3-year event-free survival was 42%. Univariate 
predictors of event-free survival were a lower grade of mitral 
regurgitation, lower MGH total echocardiographic s ore, lower 
MGH leaflet thickness subscore and lower prevalvotomy left 
ventricular systolic pressure. Only grade of mitral regurgitation 
after valvotomy predicted event-free survival by multivariate 
analysis. 
Conclusions. Inoue mitral valvotomy in patients with severe 
valvular and subvalvular deformity has a high technical success 
rate and good immediate hemodynamic result but a high cardio- 
vascular event rate in follow-up. Mitral valve replacement should 
be considered in surgical candidates with an MGH total echocar- 
diographic score >10 because it may be able to provide better 
long-term event-free survival. Balloon valvotomy remains a rea- 
sonable palliative therapeutic option for some patients with severe 
valvular deformity and high surgical risk. 
(JAm CoU Cardiol 1995;25:1129-36) 
Since the first description of percutaneous balloon mitral 
valvotomy by Inoue in 1984, it has become the procedure of 
choice for many patients with acquired mitral stenosis. Both 
immediate and long-term results have been excellent in a 
majority of patients, but less optimal results have been 
described in patients with more severe valvular and subval- 
vular deformity as determined by echocardiographic scoring 
systems. These patients obtain less optimal immediate he- 
modynamic results (1-8) and have a higher likelihood of 
restenosis (4,9,10) and a higher cardiovascular event rate 
(4,11,12). 
Recently, the Inoue balloon has become available for 
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clinical use in the United States. Its unique hourglass 
configuration results in a technically easier and quicker 
procedure with immediate results similar to those obtained 
by the single- or double-balloon method. Only a few reports 
describe the influence of patient selection on results of 
Inoue percutaneous balloon valvuloplasty in North Ameri- 
can patients (13,14). These studies suggest hat the imme- 
diate results using the Inoue balloon are less influenced by 
valvular and subvalvular morphology and that this proce- 
dure might be appropriate in patients with severe deformity. 
However, the long-term outcome of Inoue balloon valvot- 
omy in patients with severe valvular and subvalvular defor- 
mity is not known. 
This study identified a group of patients with significant 
valvular and subvalvular deformity and evaluated the immedi- 
ate and short- and long-term results of percutaneous Inoue 
balloon mitral valvotomy. In addition, we identified predictors 
of outcome and compared two echocardiographic s oring 
systems currently used in selecting patients for balloon val- 
votomy. 
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Table 1. Massachusetts General Hospital and University of Southern California Echocardiographic 
Scoring Systems 
Massachusetts General Hospital Score 
Leaflet mobility 
Grade 1 Highly mobile valve with restriction only of leaflet ips 
Grade 2 Midportion and base of leaflets have reduced mobility 
Grade 3 Valve leaflets move forward in diastole mainly at base 
Grade 4 No or minimal forward movement of leaflets in diastole 
Leaflet thickening 
Grade 1 Leaflets near normal (4-5 ram) 
Grade 2 Midleaflet hickening; marked thickening of margins 
Grade 3 Thickening extends through entire leaflets (5 8 ram) 
Grade 4 Marked thickening of all leaflet issue (>8-10 ram) 
Subvalvular thickening 
Grade I Minimal thickening of chordal structures just below valve 
Grade 2 Thickening of chordae xtending up to one-third of chordal ength 
Grade 3 Thickening extending to distal third of chordae 
Grade 4 Extensive thickening and shortening of all chordae xtending down to papillary muscle 
Valvular calcification 
Grade 1 Single area of increased echocardiographic brightness 
Grade 2 Scattered areas of brightness confined to leaflet margins 
Grade 3 Brightness extending into midportion of leaflets 
Grade 4 Extensive brightness through most leaflet issue 
University of Southern California Score 
Leaflet motion 
Grade 0 (mild) 
Grade I (moderate) 
Grade 2 (severe) 
Leaflet thickness 
Grade 0 (mild) 
Grade 1 (moderate) 
Grade 2 (severe) 
Subvalvular disease 
Grade 0 (absent-mild) 
Grade 1 (moderate) 
Grade 2 (severe) 
Commissural calcium 
Grade 0 (absent) 
Grade 1 (one commissure) 
Grade 2 (two commissures) 
H/L ratio ->0.45 
H/L ratio 0.26-0.44 
H/L ratio <0.25 
MV/PWAo thickness ratio 1.5-2.0 
MV/PWAo thickness ratio 2.1-4.9 
MV/PWAo thickness ratio >5.0 
Thin, faintly visible chordae tcndincac 
Areas of increased ensity equal to endocardium 
Areas denser than endocardium with thickened chordae tendineae 
Homogeneous density of MV orifice 
Increased ensity of anterior/posterior commissure 
Increased ensity of both commissures 
H/L - height/length ratio of dome of mitral valve (MV); PWAo thickness of aortic posterior wall. 
Methods  
Study patients and echocardiographic scoring. The study 
included 72 patients from the multicenter Inoue registry with 
total echocardiographic s ores ->10 using the Massachusetts 
General Hospital (MGH) criteria (Table 1, Fig. 1). These 
patients were derived from the entire registry of 550 patients 
who underwent valvotomy at 22 centers from June 1989 to July 
1992. 
A total of 90 patients (from 11 of the 22 centers) had total 
echocardiographic s ores ->10, as scored by the individual 
investigators and reported to the central registry. Two investi- 
gators (J.R.P., H.C.H.) reviewed the original prevalvotomy 
transthoracic e hocardiograms u ing strict criteria to eliminate 
interinstitutional v riability in scoring. Using the MGH criteria 
(3), four aspects of valve morphology (leaflet mobility, thick- 
ening, calcification and subvalvular thickening) were individu- 
ally graded on a scale of 1 to 4 from mild to severe. The total 
echocardiographic s ore was obtained by adding the four 
individual scores to yield a final score of 4 to 16. Each 
echocardiogram was also scored using the University of South- 
ern California (USC) criteria (6), which assign a score of 0 to 
2 to leaflet motion, leaflet thickness, subvalvular disease and 
commissural calcium. The total echocardiographic s ore con- 
sists of the sum of leaflet motion and thickness, ranging from 
0 to 4. In six patients in whom only transesophageal chocar- 
diograms were available, USC scores were not performed. 
After rescoring, 69 patients had total MGH scores ->10, and 18 
patients were eliminated from further analysis. Three echocar- 
diograms could not be obtained and were included on the basis 
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Figure 1. Flowchart of patient selection and results. The 72 
study patients were selected from among 550 patients in the 
multicenter Inoue registry by a Massachusetts General Hospital 
(MGH) echocardiographic (Echo) score ->10. Rescoring of the 
echocardiograms at a single center eliminated 18 patients (20%). 
The results of valvotomy are shown. MVR = mitral valve 
replacement; NYHA = New York Heart Association. 
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22 Patients (31%) 9 Patients (13%)J 32 Patients (45%), 
of their original scores. The final study group therefore in- 
cluded 72 patients. 
Procedure. Inoue balloon mitral valvotomy was accom- 
plished by the anterograde transseptal technique as previously 
described (13,15). Baseline hemodynamic and cardiac output 
measurements were obtained. The maximal balloon size was 
empirically chosen in relation to the patient's height. The 
balloon was introduced in its low profile configuration i to the 
left atrium over a 0.025-in. (0.0635-cm) stainless teel guide 
wire. The balloon was maneuvered with the aid of a preformed 
steering stylet across the mitral valve. The initial inflation was 
usually performed at a diameter 4 mm less than the maximal 
size, and individual inflations lasted -5  to 10 s. Subsequent 
inflations increased in 0.5 to 2-ram increments othe maximal 
balloon size until an adequate transmittal gradient reduction 
was achieved or until significant mitral regurgitation devel- 
oped. The final hemodynamic variables and cardiac output 
were obtained with the catheter in the left atrium to reduce 
error caused by atrial septal defect blood flow. Left ventricu- 
lography was performed in most patients (86%) to compare 
the grade (0 to 4) of mitral regurgitation before and after 
valvotomy. 
Assessment of results. The mitral valve area before and 
after valvotomy was calculated using the Gorlin formula. To 
evaluate immediate results, an optimal result was defined as 
->50% increase in mitral valve area or a final area ->1.5 cm z 
with no major complications (16). Major complications were 
death, cardiac tamponade, systemic embolism, an increase in 
mitral regurgitation of three grades or a pulmonary/systemic 
shunt ratio ->2.0 across the iatrogcnic atrial septal defect. 
End points for clinical follow-up included mitral valve 
replacement (or a second mitral valvotomy) and death. Oth- 
erwise, follow-up was based on New York Heart Association 
functional class as obtained by the individual centers. 
Statistical analysis. Data were entered into an Excel 
spreadsheet (Microsoft Corporation) and analyzed using SPSS 
for Windows (SPSS Inc.) on an IBM-compatible personal 
computer. Twenty-six clinical, procedural, eehocardiographic 
and hemodynamic variables were evaluated to identify predic- 
tors of an optimal hemodynamic result. An additional nine 
postprocedural hemodynamic variables were examined in the 
survival analysis. Statistical comparison of continuous variables 
was accomplished with the Student unpaired two-tailed t test. 
Categoric variables were compared using chi-square analysis. 
To identify predictors of immediate success, the Student 
unpaired t test and chi-square analysis identified univariate 
predictors. Logistic regression was then performed to identify 
which of the univariate predictors were significant by multiva- 
riate analysis. To identify predictors of event-free survival, 
Kaplan-Meier estimates and Cox proportional hazards regres- 
sion were performed. Pearson correlation coeificients were 
calculated to compare chocardiographic scoring systems. All 
results are reported as mean value _+ SD and were considered 
significant at p < 0.05. 
Resu l ts  
Study patients. The 72 study patients (55 women [76%], 17 
men [24%]) had an average age of 63 +_ 14 years (range 29 to 
87) (Table 2). Before the procedure, all patients were symp- 
tomatic, and 83% were in functional class III or IV, 55% in 
class III and 28% in class IV. Atrial fibrillation was present in 
52% of patients. Eleven patients (15%) had undergone previ- 
ous surgical commissurotomy. Mean baseline mitral valve area 
was 0.9 _+ 0.3 cm 2, and left atrial and pulmonary artery 
pressures were elevated (Table 2). 
Mean total echocardiographic score by the MGH criteria 
was 11.7 +_ 1.5. Individual scores for valvular thickness (3.2 +_ 
0.7) and valvular calcification (3.2 + 0.6) were significantly 
(p < 0.001) higher than those for leaflet mobility (2.7 +_ 0.7) 
and subvalvular thickness (2.7 + 0.7). Mean total echocardio- 
graphic score by the USC criteria was 2.1 + 0.7. 
Immediate and short-term results of balloon valvotomy. 
Balloon mitral valvotomy was technically successful in 69 
(96%) of the 72 patients. The hemodynamic variables mea- 
sured and calculated before and after the procedure are listed 
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Table 2. Clinical Characteristics, Echocardiographic S ores and 
Hemodynamic Results for 72 Study Patients 
Mean _+ SD Range 
Age (yr) 
NYHA functional c ass 
MGH echocardiographic score 
Leaflet mobility 
Leaflet hickness 
Subvalvular thickness 
Valvular calcification 
USC echocardiographic score 
Leaflet motion 
Leaflet hickness 
Subvalvular disease 
Commissural calcium 
Cardiac output (liters/min) 
Before MV 
After MV 
Mitral valve gradient (mm Hg) 
Before MV 
After MV 
Mitral valve area (cm z) 
Before MV 
After MV 
Left atrial pressure (mm Hg) 
Before MV 
After MV 
PA mean pressure (ram Hg) 
Before MV 
After MV 
Mitral regurgitation (grade) 
Before MV 
After MV 
No. of inflations 
Maximal balloon size (mm) 
63.3 -+ 14.3 29-87 
3.1 + 0.7 2-4 
11.7 ± 1.5 10-16 
2.7 -+ 0.7 2-4 
3.2 -+ 0.7 2-4 
2.7 _+ 0.7 1-4 
3.2 + 0.6 2-4 
2.1 ± 0.7 0-4 
1.1 + 0.6 0-2 
1.0 + 0.3 0 2 
1.2 + 0.7 0-2 
1.6 _+ 0.6 0-2 
3.7 ± 1.1 1.4-6.8 
4.2 _+ 1.2' 2.0-7.5 
13.3 + 5.2 2.0-30.0 
6.6 + 3.2* 0-17.0 
0.9 ± 0.3 0.3-2.0 
1.5 ± 0.5* 0.5-3.3 
24.0 + 7.6 10.0-40.0 
19.4 ± 6.8* 7.0-34.0 
38.5 ± 15.0 16.0-90.0 
32.9 _+ 14.0" 18.0-92.0 
0.8 _+ 0.7 0-2 
1.3 + 0.9* 0-4 
3.1 _+ 1.6 1-8 
27.1 + 2.0 22-30 
*p < 0.05 before versus after mitral valvotomy (MV). MGH = Massachu- 
setts General Hospital; NYHA = New York Heart Association; USC = 
University of Southern California. 
in Table 2. Mean transmitral gradient decreased from 13.3 +_ 
5.2 to 6.6 _+ 3.2 mm Hg (p < 0.001), and mitral valve area 
increased from 0.9 _+ 0.3 to 1.5 - 0.5 cm 2 (p < 0.001). Immedi- 
ate optimal results, as previously defined, were obtained in 46 
patients (64%). 
Mean grade for mitral regurgitation increased from 0.8 +_ 
0.7 to 1.3 + 0.9 (p < 0.001). Mitral regurgitation i creased two 
or more grades in five patients (7%). Five patients (7%) 
experienced procedural complications. One patient had a 
cerebrovascular accident, and two patients required lower 
extremity arterial embolectomy for arterial thrombosis. One 
patient developed severe mitral regurgitation (grade 0 before 
to 4 after balloon valvotomy) that required emergency mitral 
valve replacement. Finally, one patient with known severe 
coronary artery disease experienced a myocardial infarction 
that was treated successfully by urgent coronary angioplasty. 
Short-term results were evaluated 3 months after the pro- 
cedure (Table 3). Follow-up was not available for two patients 
(3%). At that time, seven patients (10%) required early mitral 
valve replacement, mostly for mitral regurgitation. Three 
Table 3. Short- (3-month) and Long-Term Outcome for All 
72 Patients 
Status 
Long-Term 
Short-Term, 
No. of Pts No. of mo 
(%) Pts (%) (mean _+ SD) 
NYHA class I or II 50 (71%) 32 (45%) 22.9 _+ 11.0 
NYHA class lIl or IV 7 (10%) 4 (6%) 25.8 _+ 12.8 
MVR (or repeat PBV) 7 (10%) 22 (31%) 13.2 _+ 10.6 
Death 3 (4%) 9 (13%) 11.6 _+ 13.9 
Incomplete procedure 3 (4%) 3 (4%) --  
Lost to follow-up 2 (3%) 2 (3%) -- 
MVR = mitral valve replacement; NYHA = New York Heart Association; 
PBV = percutaneous balloon valvotomy. 
patients (4%) died, all of congestive heart failure. Fifty pa- 
tients (71%) were in functional class I or II. 
Long-term results of balloon valvotomy. Mean follow-up 
of patients who had not experienced a clinical end point (mitral 
valve replacement or death) was 22.9 + 11.0 months. 
Follow-up was again not available for the same two patients 
(3%). Mitral valve replacement (or repeat valvotomy in 2 
patients) was performed in 22 patients (31%) at a mean of 
13.2 _+ 10.6 months after valvotomy. A total of nine patients 
(13%) died at a mean of 11.6 _+ 13.9 months. Seven patients 
died of progressive congestive heart failure, one of cancer and 
one of sepsis. Thirty-two patients (45%) were in functional 
class I or II at their last clinical evaluation. Figure 2 shows an 
event-free survival for our study patients of 42% at 3 years. 
Survival for unselected patients in the entire Inoue registry 
(17), which includes patients in the present study, is also shown 
in Figure 2. 
Predictors of immediate and long-term results. Univariate 
predictors of an optimal hemodynamic result included male 
gender, sinus rhythm and a lower commissural calcium score 
(USC criteria) (Fig. 3). Eighty-eight percent of men had an 
optimal result compared with 60% of women (p < 0.05). 
Eighty-one percent of patients in sinus rhythm had an optimal 
Figure 2. Kaplan-Meier event-free survival (freedom from death, 
mitral valve replacement or repeat valvotomy) for the study patients 
(pts) up to 3 years compared with that for the entire Inoue registry 
patients, including those with low echocardiographic scores (data from 
Feldman et al. [17]). 
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Figure 3. Univariate predictors (p < 0.05) of an optimal immediate 
result, defined as >-50% increase in mitral valve area or a final area 
>1.5 cm 2 with no major complications. The percent of patients 
achieving an optimal result for each variable is plotted on the ordinate. 
Only sinus rhythm was predictive of an optimal result in multivariate 
analysis (*p < 0.05). A-Fib = atrial fibrillation; comm = commissural; 
USC = University of Southern California echocardiographic score. 
result versus 52% of those in atrial fibrillation (p < 0.05). The 
USC commissural calcium score (p < 0.01) also predicted 
success, with an optimal result inversely proportional to the 
number of commissures calcified. Valves with both commis- 
sures calcified had a 59% success rate, and those with one 
calcified had a 76% success rate; only two patients in this series 
had no commissural calcium, and an optimal result was 
obtained in both. Neither total echocardiographic score pre- 
dicted early outcome (p = 0.36 and p -- 0.42 for MGH and 
USC scores, respectively). Multivariate analysis by logistic 
regression using the previous three variables identified only 
sinus rhythm as predicting success (p < 0.05). 
Event-free survival was defined as freedom from mitral 
valve replacement (or repeat valvotomy) and death. Univariate 
predictors of improved event-free survival were a lower MGH 
total cchocardiographic score (p < 0.05), lower MGH leaflet 
thickness ubscore (p < 0.05), lower prevalvotomy left ventric- 
ular systolic pressure (p < 0.05) and smaller degree of mitral 
regurgitation as measured by contrast ventriculography after 
valvotomy (p < 0.01). Multivariate analysis using these four 
variables identified only degree of mitral regurgitation after 
valvotomy (p < 0.05) as predictive of event-free survival. 
Figures 4 and 5 demonstrate event-free survival by MGH total 
echocardiographic s ore and grade of mitral regurgitation 
after valvotomy. 
Influence of echoeardiographic score. Reevaluation of the 
original echocardiograms resulted in the elimination of 18 of 
the 90 echocardiograms (20%) from the study population due 
to rescoring below 10. Twenty-eight percent of the echocardio- 
grams had the same total MGH echocardiographic s ore as 
was originally reported by the individual centers. Only 8% 
were rescored with the identical four subcomponent scores. 
Comparison of the MGH and USC echocardiographic 
scores demonstrated a significant positive correlation both 
between total scores and between several of the individual 
components of each scoring system. Total echocardiographic 
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Figure 4. Kaplan-Meier 3-year event-free survival is shown for pa- 
tients with Massachusetts General Hospital total echocardiographic 
scores of 10 to 11, 12 to 13 and 14 to 16. This variable was a significant 
univariate predictor of outcome (p < 0.05). 
scores were correlated with a correlation coefficient of 0.46 
(p < 0.001). Subscores for leaflet motion (r = 0.59, p < 0.001) 
and subvalvular disease (r = 0.71, p < 0.001) were highly 
correlated, but the scores for valvular thickness (r =- 0.01, p = 
0.91) and calcification (r = 0.14, p = 0.29) did not correlate. 
Discuss ion  
We identified 72 patients from the North American multi- 
center lnoue registry with severe valvular and subvalvular 
disease as defined by a total MGH echocardiographic score 
->10. Such patients are usually considered poor or suboptimal 
candidates for both balloon valvotomy and surgical commis- 
surotomy (18), but few studies have specifically examined 
outcomes after Inoue balloon valvotomy. In the present study, 
we attempted to carefully define this group of patients by 
reviewing all the echocardiograms at a central site, which 
resulted in elimination of 20% of patients with echocardio- 
grams previously scored as ->10 at contributing registry insti- 
Figure 5. Actuarial 3-year event-free survival for patients with severe 
valvular and subvalvular deformity grouped by the grade of mitral 
regurgitation after valvotomy. Mitral regurgitation was graded (none 
to 4+) by left ventriculography and was the only significant predictor 
of poor long-term outcome identified by multivariate Cox regression 
analysis. 
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tutions. In addition, to our knowledge we obtained the first 
long-term follow-up of such patients after Inoue balloon 
valvotomy in North America. 
Early valvotomy results. A number of investigators have 
reported the results of Inoue balloon valvotomy, both here and 
abroad (13-15,19-22). The results of the North American 
multicenter registry are typical (13,14). In general, mitral valve 
area increases from 1.0 to 1.8 cm 2 with an immediate success 
rate of -75% and a low rate of major complications (14). 
Complications may include severe mitral regurgitation, sys- 
temic embolism, cardiac tamponade and significant interatrial 
shunts. 
Several studies have also examined the early results of 
Inoue valvotomy in patients with a suboptimal morphology 
(13,15,19). Feldman et al. (13) described the results of val- 
votomy in 44 patients with an MGH echocardiographic score 
>8. Their postvalvotomy mitral valve area was 1.7 + 0.5 cm 2, 
which was similar to the result obtained in 105 patients with 
echocardiographic s ores -<8. They concluded that valve de- 
formity did not have a significant effect on early results with the 
Inoue balloon. In contrast, Hung et al. (19) reported the results 
of Inoue valvotomy in 74 Chinese patients with severe valvular 
and subvalvular calcification. Although the mitral valve area 
increased to 1.8 + 0.5 cm ~-, valvular morphology was a signif- 
icant predictor of a suboptimal hemodynamic result. Likewise, 
Nobuyoshi et al. (15) described the results of Inoue valvotomy 
in 106 Japanese patients; the early hemodynamic and symp- 
tomatic improvement was significantly worse in 10 patients 
with rigid valves. The final mitral valve area in these patients 
increased to 1.6 _+ 0.7 cm2, and only 60% of patients improved 
symptomatically compared with 95% of the remaining pa- 
tients. 
Our patients with severe valvular and subvalvular disease 
are similar to those in previous tudies of less selected patients 
with more pliable valves with regard to gender, incidence of 
previous commissurotomy and severity of mitral stenosis but 
were older by -10 years. In the present study, valvotomy was 
technically successful in96% of patients, arate similar to those 
reported in large series of patients with lower mean echocar- 
diographic scores (13-15,19,21). However, the immediate he- 
modynamic result (1.5 _+ 0.5 cm 2) was lower than the result in 
the entire Inoue balloon registry (1.8 _+ 0.6 cm 2) (14,17). 
Similarly, by a previous definition of optimal hemodynamic 
success, 64% of our patients with severe valvular and subval- 
vular disease achieved an optimal result compared with 74% in 
the entire registry (14). 
Compared with previous tudies, we confirmed that balloon 
valvotomy can be safely performed in patients with a subopti- 
mal morphology with an acceptable but smaller improvement 
in mitral valve area. Previous reports from the Inoue multi- 
center egistry failed to demonstrate short-term differences in 
such patients, probably because of greater interinstitutional 
variability in echocardiographic s oring, the inclusion of pa- 
tients with scores between 8 and 10 and the much smaller 
number of patients with an echocardiographic s ore ->10. 
Short-term follow-up. Short-term results were evaluated at 
3 months, by which time 10% of patients required mitral valve 
replacement, usually for mitral regurgitation. Seven percent of 
patients had a significant increase in grade of mitral regurgi- 
tation immediately after the procedure, which appeared to be 
similar to that reported in other series and in the registry as a 
whole (13-15,19,21,22). However, mean grade of mitral regur- 
gitation increased more in these patients from a higher base- 
line, and more patients required early mitral valve replacement 
for mitral regurgitation than in previous series. Neither left 
ventriculography nor echocardiographic Doppler examination 
was performed in seven patients. It is unlikely that the inci- 
dence of severe mitral regurgitation would have been higher if 
these patients were included, because six were free of events at 
last follow-up, and one died of a cerebral vascular accident. 
The mechanism of severe mitral regurgitation with the 
Inoue balloon was previously examined by Herrmann et al. 
(23), who demonstrated that the most frequent causes of 
regurgitation were rupture of the chordae tendineae and 
tearing of a leaflet, usually the posterior one. One would 
expect that leaflet tears would be more frequent in more 
calcified valves and that chordal rupture would be more 
frequent in patients with severe subvalvular deformity. Echo- 
cardiograms after valvotomy were not examined inthe present 
study, but none of the echocardiographic variables within this 
selected patient group predicted the occurrence of mitral 
regurgitation. Previous tudies with a larger range of echocar- 
diographic scores have also failed to identify specific predictors 
of this complication (14,16,23). 
Long-term follow-up. Several previous investigators have 
examined the intermediate and long-term results of balloon 
valvotomy. Palacios (24) described results in 320 patients after 
single- and double-balloon valvotomy and reported by actuar- 
ial estimates an event-free survival of 77%, with 19% requiring 
mitral valve replacement at 2 years. Three-year event-free 
survival was 70%. In contrast, patients with MGH echocardio- 
graphic scores >8 had poorer esults, with a 3-year event-free 
survival of 46% (24). Cohen et al. (11) provided 5-year (mean 
3) actuarial data for 145 patients after predominantly single- 
balloon procedures. They reported a similar 2-year event-free 
survival of 74% and a 5-year event-free survival of 51%. In that 
study, patients with MGH echocardiographic scores >8 had an 
event-free survival of 58% at 2 years and 28% at 5 years (11). 
Finally, a preliminary study from the Inoue multicenter registry 
(17) reported by actuarial methods an event-free survival of 
77% at 3 years. 
In the present study, we demonstrated a poorer outcome in 
patients with severe valvular and subvalvular disease. With a 
2-year mean follow-up, mitral valve replacement was required 
in 31% of patients, and only 45% were in functional class I or 
II. Actuarial event-free survival was only 42% by 3 years, 
comparable to that achieved with the single- and double- 
balloon techniques in similar patients (11,24). These results are 
less than half that achieved in less selected patient series 
(11,17,24). We therefore demonstrated that both the short- 
and long-term results of Inoue valvotomy in patients with 
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severe valvular and subvalvular disease are very similar to 
those obtained with the single- or double-balloon techniques. 
The unique geometry of the Inoue balloon appears to offer no 
advantage in this highly selected group of patients. 
Predietors of outcome. Factors that have previously been 
demonstrated to adversely affect the early hemodynamic re- 
sults of balloon valvotomy include atrial fibrillation (2,4,7,19), 
echocardiographic morphology (2-7,9,19), balloon size (2,5- 
7,25), advanced age (4,19) and cardiac output (6,25). In the 
present study, we confirmed that atrial fibrillation and com- 
missural calcium (USC score) were associated with less hemo- 
dynamic improvement. In addition, we demonstrated in this 
highly selected study group with severe valvular deformity that 
female gender had an adverse ffect on early outcome. 
It is likely that atrial fibrillation is a marker of more severe 
or long-standing mitral stenosis, or both, which may be less 
amenable to balloon dilation. Similarly, because the mecha- 
nism of successful percutaneous balloon valvuloplasty requires 
separation of fused commissures (1,3), it is not surprising that 
better results are obtained in valves with less commissural 
calcium. It is less clear how gender influences outcome, but this 
variable was not independently significant in multivariate 
analysis. More male than female patients were in sinus rhythm 
(56% vs. 46%), but this difference was not statistically signifi- 
cant. 
Several investigators have demonstrated that echocardio- 
graphic variables can predict long-term outcome with single- 
and double-balloon techniques (4,9-11). Chen et al. (20) 
demonstrated in young Chinese patients that severe valvular 
and subvalvular disease increased the rate of restenosis after 
Inoue valvotomy, although Herrmann et al. (14) did not find a 
higher rate of early restenosis in a previous study of North 
American patients. 
However, with a more homogeneous group of patients with 
severe valvular and subvalvular disease and longer follow-up, 
the present investigation demonstrated a high rate of mitral 
valve surgery, need for repeat valvotomy and death. Univariate 
predictors of event-free survival included MGH total echocar- 
diographic score and leaflet hickness ubscore, postvalvotomy 
grade of mitral regurgitation a d prevalvotomy left ventricular 
systolic pressure. Event-free survival was particularly poor in 
patients with an Massachusetts General Hospital score ->12 
(Fig. 4). Only postvalvotomy mitral regurgitation grade was 
predictive of long-term outcome in multivariate analysis. Al- 
though the incidence of severe mitral regurgitation produced 
by valvotomy in this study was not different from that in 
previous investigations, mean grade of mitral regurgitation 
both before and after valvotomy was higher. This suggests hat 
small increases in mitral regurgitation grade may be less well 
tolerated in this older patient group and that patients with 
severe valvular deformity and more than mild preexisting 
mitral regurgitation are at greatest risk for poor long-term 
outcomes. 
Finally, we compared the MGH criteria and USC echocar- 
diographic score criteria. The subscores for leaflet motion and 
subvalvular disease were highly correlated, as were the total 
echocardiographic s ores. However, the subscores for leaflet 
thickness did not correlate, possibly because of difficulty in 
eliminating the subvalvular apparatus from measurements of 
the USC subscore. Although the USC commissural score was 
predictive of immediate r sults, only the MGH score predicted 
event-free survival. 
Study limitations. This was a retrospective study and has 
the usual limitations attributed to this form of analysis. In 
addition, an inherent selection bias was incurred because 
investigators chose patients for valvotomy and because the 
study patients were selected on the basis of one (MGH) 
scoring system. In particular, comparisons of the relative 
predictive value of the two scoring systems used in this study as 
well as comparisons of one to the other must be interpreted 
cautiously. Finally, the older age of our study patients may 
have influenced the decision for operation and limits compar- 
ison of event-free survival with that for the entire Inoue 
registry. 
Clinical implications. Percutaneous balloon mitral valvot- 
omy is a safe and efficacious treatment modality for the 
majority of patients with acquired mitral stenosis. However, 
proper patient selection is essential to achieve optimal results. 
In the present investigation, we demonstrated that both imme- 
diate and long-term results of Inoue balloon valvotomy are 
adversely influenced by severe valvular and subvalvular defor- 
mity. Procedural technical success remains high in such pa- 
tients, but smaller mitral valve areas are achieved, and the 
long-term event-free survival is <50% of that achieved in 
unselected patients. The most important predictor of event- 
free survival was the severity of mitral regurgitation after 
valvotomy. Mitral valve replacement may result in better 
long-term relief of mitral valve obstruction in symptomatic 
surgical candidates with total MGH echocardiographic scores 
-> 10, although comparative studies of event-free survival will 
need to include prosthetic valve complications as well. Balloon 
valvotomy remains a reasonable palliative therapeutic option 
for some patients with severe valvular deformity and high 
surgical risk. 
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